ITOS iTeos Therapeutics Inc Net earnings per share growth forecast for next year
Oncologist confidence and an alliance with a pharma behemoth confirm the status of iTeos Therapeutics (ITOS), which is reflected in the shifting analyst EPS growth estimates on the GURU.Markets daily price chart, where the latest parameter stands at 46.10. iTeos Therapeutics attracts top biologists through a flexible culture and stock options, yet the lack of profitability and rapid capital burn create significant financial risks.
Financial and market metric breakdowns for iTeos Therapeutics, Inc. (ITOS)
- stock quotes and analyst forecast:
- market capitalization data:
- company book value details:
- debt obligations and liquidity statistics:
Total Debt to Equity Ratio iTeos Therapeutics|ITOS - Long-Term Loans to Capital Ratio|Short-Term Debt to Capital iteostherapeutics.com|ITOS - Company Cumulative Debt|Debt to Book Capitalization Ratio iTeos Therapeutics|ITOS - Long-Term Debt|Company Short-Term Debt iTeos Therapeutics|Quick Liquidity Indicator iteostherapeutics.com
- earnings and valuation multiples information:
ITOS - Final Profit|Future Profit iTeos Therapeutics|ITOS - Market Price to Net Income Ratio|Forward P/E Multiple iTeos Therapeutics, Inc.|ITOS - Growth-Adjusted Payback Ratio|EV/EBITDA Multiple iTeos Therapeutics|ITOS - Profit before interest, taxes and amortization|Earnings per share for the last twelve months iTeos Therapeutics|ITOS - Earnings per share for the trailing year|Quarterly EPS earnings growth iteostherapeutics.com|ITOS - Earnings growth in current year|Net earnings per share growth forecast for next year iTeos Therapeutics
- total revenue and sales volume data:
Fundamental company analysis:ITOS, iTeos Therapeutics Inc
iTeos Therapeutics (ITOS), as a player in the immuno-oncology sector, possesses a model with massive profit leverage upon the success of a single molecule. The consensus earnings growth forecast for the coming period measures the reallocation of institutional capital, reflecting investor confidence in the commercialization of its developments. By analyzing the EPS growth prospects for the next fiscal year, an investor determines whether the market is pricing in a sharp transition for iTeos Therapeutics from a cost-heavy phase to billion-dollar revenues.
Competitors of iTeos Therapeutics
Expected earnings per share growth for next year ARGX|Earnings growth forecast for next year biontech.de|Net earnings per share growth forecast for next year Abivax Corp (ABVX)|ADMA Biologics, Inc. - Projected earnings per share growth rate for next year|Earnings growth forecast for next year PTGX (protagonist-inc.com)|Immunovant Corp (IMVT) - Expected net earnings per share growth next year|KNSA - Net earnings per share growth forecast for next year|Net earnings per one share growth forecast for next year grifols.com (GRFS)|ADPT: Earnings growth forecast for next year|Expected net earnings per share growth next year Celldex Therapeutics Inc (CLDX)|Net earnings per share growth forecast for next year Aurinia Pharma|Expected net earnings per share growth next year BioCryst Pharmaceuticals Inc BCRX|Earnings growth forecast for next year VERA|Dianthus Therapeutics, Inc. - Projected earnings per share growth rate for next year|Pharvaris - Expected earnings per share growth for next year|AbCellera Biologics Inc. - Net earnings per share growth forecast for next year|Tourmaline Bio Inc - Earnings growth forecast for next year|Net earnings per one share growth forecast for next year Intrexon (PGEN)|Pharming Group (PHAR) - Net earnings per share growth forecast for next year|Nektar Therapeutics Inc. - Expected earnings per share trend next year|Expected earnings per share growth for next year UPB|Zenas Bio (ZBIO) - Consensus forecast of earnings per share growth for next year|Expected earnings per share growth for next year IMNM (Immunome Corp)|GOSS (Gossamer Corp) - Expected earnings per share trend next year|Net earnings per share growth forecast for next year KalVista Pharmaceuticals Inc KALV|Consensus forecast of earnings per share growth for next year septerna.com (SEPN)|PVLA - Net earnings per share growth forecast for next year|Consensus forecast of earnings per share growth for next year Savara Inc SVRA|RIGL: Earnings growth forecast for next year|ANAB - Consensus forecast of earnings per share growth for next year|Net earnings per share growth forecast for next year Astria Pharma|Projected earnings per share growth rate for next year ENGN (enGene Holdings Inc.)|Expected earnings per share growth for next year RAPT (RAPT Therapeutics, Inc.)|Earnings growth forecast for next year Aerovate Therapeutics, Inc. (JBIO)|Earnings growth forecast for next year ACRS (aclaristx.com)|Kyverna Therapeutics (KYTX) - Expected net earnings per share growth next year|tizianalifesciences.com - Earnings growth forecast for next year|CABA (Cabaletta Bio, Inc.) - Projected earnings per share growth rate for next year|VTYX: Earnings growth forecast for next year|THTX - Consensus forecast of earnings per share growth for next year|Net earnings per share growth forecast for next year Avalo Therapeutics Inc|Eledon (ELDN) - Consensus forecast of earnings per share growth for next year|Net earnings per share growth forecast for next year agenusbio.com (AGEN)|CLYM (Climb Bio Inc) - Expected earnings per share trend next year|Earnings growth forecast for next year ZURA (zurabio.com)|Expected earnings per share trend next year ATYR|ADAG - Net earnings per share growth forecast for next year|ikenaoncology.com (IMA) - Expected earnings per share growth for next year|Shattuck Labs (STTK) - Net earnings per share growth forecast for next year|EQ - Consensus forecast of earnings per share growth for next year|CNTB (connectbiopharm.com) - Earnings growth forecast for next year|IMUX: Expected earnings per share trend next year|Net earnings per share growth forecast for next year Atara Biotherapeutics, Inc. (ATRA)|Consensus forecast of earnings per share growth for next year InflaRx NV|Earnings growth forecast for next year XFOR (X4 Pharmaceuticals)|Earnings growth forecast for next year Adicet Bio ACET|CELU: Expected earnings per share growth for next year|Expected earnings per share trend next year INMB (INmune Bio)|Barinthus Bio (BRNS) - Net earnings per share growth forecast for next year|Kezar Life Sciences (KZR) - Earnings growth forecast for next year|Net earnings per share growth forecast for next year sabbiotherapeutics.com|Earnings growth forecast for next year Akari Therapeutics Plc|Net earnings per share growth forecast for next year Enlivex Therapeutics Ltd (ENLV)|Q32 Bio Corp (QTTB) - Net earnings per one share growth forecast for next year|Net earnings per share growth forecast for next year GeoVax Corp GOVX|Consensus forecast of earnings per share growth for next year Edesa Biotech Corp (EDSA)|IBIO: Expected earnings per share growth for next year|Expected earnings per share trend next year CARM (carismatx.com)|XTLB: Earnings growth forecast for next year|BOLT - Consensus forecast of earnings per share growth for next year|Expected earnings per share growth for next year HCWB|Expected earnings per share growth for next year Aptevo Therapeutics Inc. (APVO)|Earnings growth forecast for next year AIM|ADTX: Net earnings per share change forecast for next year|GRI Bio - Expected earnings per share growth for next year|Consensus forecast of earnings per share growth for next year XORTX Therapeutics Inc (XRTX)|HIND: Expected earnings per share growth for next year|Revelation Biosciences (REVB) - Expected earnings per share growth for next year|Indaptus Therapeutics, Inc. (INDP) - Net earnings per share growth forecast for next year|SCNI - Consensus forecast of earnings per share growth for next year|CALI (CalciMedica) - Earnings growth forecast for next year|Earnings growth forecast for next year affimed.com|Net earnings per share growth forecast for next year Allakos Therapeutics (ALLK)|HOOK - Expected net earnings per share growth next year|Net earnings per share growth forecast for next year IGM Biosciences, Inc. IGMS|OCEA - Expected earnings per share growth for next year|TC BioPharm (Holdings) Plc - Earnings growth forecast for next year|Expected earnings per share trend next year THRD (Third Harmonic Bio, Inc.)
